Clinical pipeline note (December 2025): Novo Nordisk filed a New Drug Application (NDA) with the FDA on December 18, 2025 for CagriSema a fixed-dose weekly combination of cagrilintide + semaglutide for weight management
How Weight Loss Injections Work Ozempic, Wegovy, Mounjaro, and Zepbound effectively lower blood sugar by boosting insulin production, reducing glucagon, and slowing the digestive process
Therefore, genistein, an antioxidant, might be a potential drug for treating patients with myocardial injury
Our clinic provides personalized treatment plans to ensure each patient receives the best care tailored to their specific needs
They are a dynamic equilibrium process catalyzed by an enzyme called glutathione reductase (GR)
Yet delivery methods for HMW drugs may pose additional challenges for patients and their healthcare providers